SOUTH COAST GLOBAL MEDICAL CENTER
1. Target Overview & Investment Thesis
SOUTH COAST GLOBAL MEDICAL CENTER is a 109-bed under-performing / distressed in nan, CA with $20.2M in net patient revenue and a -9.0% operating margin. The hospital serves a payer mix of 19.2% Medicare, 19.5% Medicaid, and 61.3% commercial.
Thesis: Undervalued. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.0% to -1.6% (+736bps).
| Net Revenue HCRIS | $20.2M |
| Current EBITDA COMPUTED | $-1.8M |
| Operating Margin COMPUTED | -9.0% |
| Occupancy HCRIS | 20.3% |
| Revenue / Bed COMPUTED | $185K |
| Net-to-Gross HCRIS | 21.6% |
| Distress Probability ML | 59.0% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -9.0% places it below the state median. Among 178 size-comparable peers (54-218 beds), the median margin is -4.5%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (54-218), prioritizing same-state peers. 178 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SOUTH COAST GLOBAL MEDICAL CEN (Target) | CA | 109 | $20.2M | -9.0% |
| CITY OF HOPE NATIONAL MEDICAL | CA | 217 | $1.83B | -10.7% |
| KFH - MANTECA | CA | 213 | $796.8M | 15.2% |
| CHILDRENS HOSP & RES CNTR OAKL | CA | 155 | $687.9M | -7.1% |
| NORTHBAY HOSPITAL GROUP | CA | 204 | $676.6M | -8.2% |
| KFH - SAN LEANDRO | CA | 216 | $663.8M | 10.3% |
| CONTRA COSTA REGIONAL MEDICAL | CA | 124 | $595.0M | -29.2% |
| KFH - VALLEJO | CA | 184 | $531.7M | 0.3% |
| RANCHO LOS AMIGOS NATL.REHAB.C | CA | 83 | $512.6M | 41.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $424K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $403K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $399K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $245K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $13K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-1.8M |
| + RCM Uplift | +$1.5M |
| Pro Forma EBITDA | $-326K |
| Current Margin | -9.0% |
| Pro Forma Margin | -1.6% |
| WC Released (1x) | $774K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-2.8M | $2.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-2.8M | $2.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-2.5M | $6.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-2.5M | $6.1M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-3.1M | $-3.6M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-3.1M | $-5.0M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 20.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 59.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 178 hospitals with 54-218 beds
- Same-state prioritization (n=179)
- Comp margins: P25=-21.2% / P50=-4.5% / P75=4.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.